Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × Advanced Cancer × Clear all

Phase

Status

Sponsor Class

OTHER 67 INDUSTRY 48 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 153 Leukemia 127 Lung Neoplasms 93 Lymphoma 91 Carcinoma, Non-Small-Cell Lung 84 Sarcoma 74 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Central Nervous System Neoplasms 71 Prostatic Neoplasms 70 Colorectal Neoplasms 64 Ovarian Neoplasms 62 Head and Neck Neoplasms 60 Rectal Neoplasms 51 Squamous Cell Carcinoma of Head and Neck 48 Multiple Myeloma 46 Colonic Neoplasms 46 Leukemia, Myeloid, Acute 45 Neuroblastoma 43 Brain Neoplasms 42 Uterine Cervical Neoplasms 38 Lymphoma, Large B-Cell, Diffuse 36 Glioblastoma 36 Neoplasm Metastasis 35 Carcinoma, Ovarian Epithelial 35 Leukemia, Lymphocytic, Chronic, B-Cell 33 Fallopian Tube Neoplasms 33 Astrocytoma 33 Burkitt Lymphoma 31 Hodgkin Disease 29 Melanoma 28

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡